增加的二-2-乙烯基) 甲酸盐暴露对成人喘集群构成差异性风险
Yuan-Ting Hsu1,2, Chao-Chien Wu3, Chin-Chou Wang3,4
1National Institute of Environmental Health Sciences, National Health Research Institutes, No.35, Keyan Road, Zhunan, Miaoli County, 35053, Taiwan.
Respiratory research
|March 24, 2024
概括
暴露于增塑剂DEHP (2-乙基酸盐) 和其代谢物如MEHHP与特定的成人喘亚组有关. 这表明DEHP可能有助于非阿托皮性喘病因,对细胞因子相互作用有潜在的影响.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 2-乙烯基) 甲酸盐 (DEHP) 是一种常见的增塑剂,具有已知的内分泌干扰特性.
- 之前,DEHP暴露与喘有关,但其在非热性成人喘中的作用尚不清楚.
研究的目的:
- 调查DEHP代谢物与特定喘亚组之间的关联.
- 探索DEHP暴露,喘并发症和氧化应激和炎症的生物标志物之间的关系.
主要方法:
- 一项涉及365名喘患者和235名健康对照者的病例控制研究.
- 对尿中DEHP代谢物 (MEHP,MEHHP),氧化应激标记物,脂和炎症性细胞因子的分析.
- 统计分析包括后勤回归和相关性分析.
主要成果:
- 特定的喘集群 (E,D,C,F,A) 显示MEHHP暴露的几率明显更高.
- 没有并发症 (2型糖尿病,高血压) 的个人暴露于DEHP代谢物 (MEHP + MEHHP,MEHHP) 的几率更高.
- 在尿液中的HEL和DEHP代谢物之间发现了正相关性,在DEHP代谢物和某些细胞因子之间发现了负相关性.
结论:
- 对MEHHP和MEHP+MEHHP的高暴露与特定的喘亚组有关.
- 在喘中DEHP的作用是复杂的,可能涉及与炎症通路的相互作用.
- 需要进一步的流行病学和动物研究来证实这些发现并阐明机制.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
279
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
279


